Literature DB >> 16791133

Rapid HIV test distribution--United States, 2003-2005.

.   

Abstract

At the end of 2003, an estimated 1 million persons in the United States were living with human immunodeficiency virus (HIV) infection, including those with acquired immunodeficiency syndrome (AIDS); approximately one fourth of these persons had not had their infections diagnosed. In 2003, CDC implemented a new initiative, Advancing HIV Prevention (AHP), focused, in part, on reducing the prevalence of undiagnosed HIV infection by expanding HIV testing and taking advantage of rapid HIV tests that enable persons to receive results within 30 minutes, instead of the 2 weeks typically associated with conventional tests. In support of AHP strategies, during September 2003-December 2005, CDC purchased and distributed rapid HIV tests to expand testing and assess the feasibility of using rapid tests in new environments (e.g., outreach settings or emergency departments). This report summarizes the results of this rapid HIV-test distribution program (RTDP), in which CDC distributed tests to 230 organizations in the United States and identified 4,650 (1.2%) HIV infections among 372,960 rapid tests administered. The results suggest that RTDP helped scale up rapid HIV-testing programs in the United States and enabled diagnosis of HIV in persons who might not have had their infections diagnosed otherwise.

Entities:  

Mesh:

Year:  2006        PMID: 16791133

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Home testing to detect human immunodeficiency virus: boon or bane?

Authors:  Sheldon Campbell; Roger Klein
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Testing for HIV infection in the United States.

Authors:  Lindsey L Wolf; Rochelle P Walensky
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  Advancing HIV prevention demonstration projects: new strategies for a changing epidemic.

Authors:  James D Heffelfinger; Patrick S Sullivan; Bernard M Branson; Timothy D Mastro; David W Purcell; Sean D Griffiths; Raul A Romaguera; Robert S Janssen
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

4.  Effectiveness of the U.S. national HIV testing day campaigns in promoting HIV testing: evidence from CDC-funded HIV testing sites, 2010.

Authors:  Michelle Van Handel; Mesfin S Mulatu
Journal:  Public Health Rep       Date:  2014 Sep-Oct       Impact factor: 2.792

5.  HIV voluntary counselling and testing for African communities in London: learning from experiences in Kenya.

Authors:  A Prost; W S Sseruma; I Fakoya; G Arthur; M Taegtmeyer; A Njeri; A Fakoya; J Imrie
Journal:  Sex Transm Infect       Date:  2007-10-02       Impact factor: 3.519

6.  High Substance Use and HIV Risk Behavior Among Young Argentine Men Who Have Sex with Men.

Authors:  Iván C Balán; Timothy Frasca; María A Pando; Rubén O Marone; Victoria Barreda; Curtis Dolezal; Alex Carballo-Diéguez; María M Ávila
Journal:  AIDS Behav       Date:  2018-04

7.  Cost-effectiveness of finding new HIV diagnoses using rapid HIV testing in community-based organizations.

Authors:  Ram K Shrestha; Hollie A Clark; Stephanie L Sansom; Binwei Song; Holly Buckendahl; Cindy B Calhoun; Angela B Hutchinson; James D Heffelfinger
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

8.  False positive rate of rapid oral fluid HIV tests increases as kits near expiration date.

Authors:  Shelley N Facente; Teri Dowling; Eric Vittinghoff; Deanna L Sykes; Grant N Colfax
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance.

Authors:  Laura G Wesolowski; Duncan A Mackellar; Steven F Ethridge; Julia H Zhu; S Michele Owen; Patrick S Sullivan
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.